Person who experienced the adverse event (patient)
| Event ID | CASE | I F COD | FOLL SEQ | IMAGE | EVENT DT | MFR DT | FDA DT | REPT COD | MFR NUM | MFR SNDR | AGE | AGE COD | GNDR COD | E SUB | WT | WT COD | REPT DT | OCCP COD | DEATH DT | TO MFR | CONFID | REPORTER COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 8248769 | 8461041 | F | 8248769-2 | 20120329 | 20120331 | EXP | PHHY2012AU022108 | NOVARTIS PHARMACEUTICAL CORPORATION | YR | F | Y | 20120331 | MD | AUSTRALIA |
Drug(s) used by person
| Event ID | DRUG SEQ | ROLE COD | DRUGNAME | VAL VBM | ROUTE | DOSE VBM | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 8248769 | 1019282821 | C | ZANTAC | 1 | 300 MG, QD | ||||||
| 8248769 | 1019282820 | C | LERCANIDIPINE | 1 | ORAL | 10 MG, UNK | |||||
| 8248769 | 1019282818 | PS | ZOLEDRONOC ACID | 1 | INTRAVENOUS | 5 MG, UNK | 021817 | ||||
| 8248769 | 1019282819 | C | PERINDOPRIL ERBUMINE | 1 | ORAL | 5 MG, BID |
Indications of drugs used
| Event ID | DRUG SEQ | INDI PT |
|---|---|---|
| 8248769 | 1019282821 | GASTROOESOPHAGEAL REFLUX DISEASE |
| 8248769 | 1019282820 | HYPERTENSION |
| 8248769 | 1019282818 | OSTEOPOROSIS |
| 8248769 | 1019282819 | HYPERTENSION |
Outcome of event
| Event ID | OUTC COD |
|---|---|
| 8248769 | OT |
Reactions reported
| Event ID | PT |
|---|---|
| 8248769 | GINGIVAL ULCERATION |
| 8248769 | SWOLLEN TONGUE |
| 8248769 | PALPITATIONS |
| 8248769 | HEART RATE IRREGULAR |
| 8248769 | GINGIVAL BLEEDING |
| 8248769 | FEELING ABNORMAL |
| 8248769 | GINGIVAL INFECTION |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|
| 8248769 | 1019282820 | 20050101 | |||
| 8248769 | 1019282818 | 20110420 | |||
| 8248769 | 1019282819 | 20040101 |